C-SHRED
Natural health product licensed in Canada
- Other names
- Blade, CardiaShred, Elevate Series, Final Cutz, Final Form, Heuer MD Research, Infinite Labs, MDX-32, MDx-32, MoreDefinition X-32, X32MD, XMD-32
- Licence holder
- CHI Group Inc.
- NPN or DIN-HM
- 80042112
- Status
- Active licence
- Licence date
- 3 May 2013
- Revision date
- 12 January 2015
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-Triméthylxanthine Source : Camellia sinensis - feuille | 37 mg | Not calculated |
| N-[Imino(phosphonoamino)méthyl]-N-méthylglycine Source : Creatine phosphate | 375 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 1 mg | Not calculated |
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium Source : Beta vulgaris - Racine | 75 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 5 % Caffeine | Not specified | Not calculated |
| Potassium Source : Oryza sativa - Graine | 15 mg | Not calculated |
| (3bêta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol Source : Cholécalciférol | 3.75 mcg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 45 % EGCG | 150 mg | Not calculated |
| Panax ginseng Source : Écorce de racine | 25 mg | Not calculated |
| Folate Source : Saccharomyces cerevisiae - cellule entière | 60 mcg | Not calculated |
| Biotine Source : Saccharomyces cerevisiae - cellule entière | 112.5 mcg | Not calculated |
| Riboflavine Source : Saccharomyces cerevisiae - cellule entière | 0.766 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Stéarate de magnésium, Silice, Cellulose - microcrystalline, Carbonate de calcium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help In weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80042112
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.